DrugCards

27/11/2025

🇺🇦 Партнер соціального впливу — ініціатива ДонорUA
Ми раді поділитися чудовою новиною! На нашій конференції буде представлена команда ДонорUA — першої та єдиної в Україні цифрової екосистеми для рекрутингу та координації донорів крові.
З 2015 року вони об’єднують донорів, лікарні та пацієнтів, формуючи культуру свідомого та регулярного донорства.
Сьогодні на платформі вже понад 200 000 користувачів, які допомагають рятувати життя по всій країні.
🩸 Під час події працюватиме зона “Моя група крові”
Кожен охочий зможе визначити свою групу крові за допомогою швидких тестів Eldon Card і, за бажанням, долучитися до бази донорів.
Маленький крок може змінити чиюсь долю ❤️
Реєстрація триває — приєднуйтесь!
👉 https://drugcards-26507628.hubspotpagebuilder.eu/drug...

🇬🇧Our Social Impact Partner for — DonorUA
We’re happy to share that DonorUA will join our conference as a Social Impact Partner.
DonorUA is the first and only digital ecosystem in Ukraine designed to recruit and coordinate blood donors — a platform that has been shaping a culture of conscious, regular blood donation since 2015.
Today, DonorUA brings together more than 200,000 users across the country, helping hospitals and patients receive donor blood safely and on time.
🩸 At the conference, you’ll find the “My Blood Type” zone, where anyone can quickly determine their blood type using Eldon Card rapid tests and, if willing, sign up as a potential donor.
A small action can save someone’s life ❤️
Registration for the conference is open — join us!
👉 https://drugcards-26507628.hubspotpagebuilder.eu/drug...

25/11/2025

English version below. 📄 Друзі, маємо чудову новину!
У Щотижневику «Аптека» вийшла нова стаття про те, як формат eCTD змінює процес реєстрації ліків в Україні — і як ми реалізували цей підхід у DrugCard.

У матеріалі розповідаємо, як цифрове подання досьє працює на практиці, чому це спрощує роботу компаній та як допомагає рухатися до євроінтеграції.

Запрошуємо до прочитання 👇

📄 Great news! Our new article has just been published in Shchotyzhnevyk Apteka, covering how the eCTD format is transforming the medicinal product registration process in Ukraine — and how we’ve built this workflow inside DrugCard.

The piece explains how digital dossier submission works in practice, why it simplifies the work for pharma companies, and how it supports Ukraine’s move toward EU alignment.

I invite you to check it out 👇

18 серпня 2025 р. Україна офіційно перейшла на формат електронного загального технічного документа (electronic Common Technical Document — eCTD) — міжнародний стандарт електронного ...

25/11/2025

𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗷𝘂𝘀𝘁 𝗴𝗼𝘁 𝗮 𝗺𝗮𝗷𝗼𝗿 𝘂𝗽𝗴𝗿𝗮𝗱𝗲!
Remember when monitoring medical literature meant dozens of tabs and endless PDFs?
📢Good news - those days are gone!

🔥Our latest blog post explores how the DrugCard platform’s new AI literature screening features are revolutionising pharmacovigilance. From smart prioritisation with the red man alerts to AI-generated summaries and instant collaboration, specialists can now focus on what truly matters: patient safety.

🚀Curious how AI is reshaping the world of drug safety? Check out the full story and see why mornings in pharmacovigilance are now faster, wiser, and way more interesting.
🔗 Read the full article on our blog: https://drug-card.io/blog/pharmacovigilance-made-smarter-with-new-ai-literature-screening-on-the-platform/

19/11/2025

🌟 𝗜𝗻 𝘁𝗵𝗲𝘀𝗲 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗶𝗻𝗴 𝘁𝗶𝗺𝗲𝘀 𝗳𝗼𝗿 𝗨𝗸𝗿𝗮𝗶𝗻𝗲, 𝘀𝘁𝗮𝘆𝗶𝗻𝗴 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱 𝗮𝗻𝗱 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗲𝗮𝗰𝗵 𝗼𝘁𝗵𝗲𝗿 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗲𝘃𝗲𝗿.

That’s why we decided to bring the Ukrainian pharmacovigilance community together and organise 𝗮 𝗳𝗿𝗲𝗲, 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗮𝗹 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 focused on the technologies shaping our future.

𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝗞𝘆𝗶𝘃 𝗗𝗿𝘂𝗴 𝗦𝗮𝗳𝗲𝘁𝘆 𝗗𝗮𝘆 — 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗻𝗼𝘄 𝗼𝗽𝗲𝗻!
📅 𝟭𝟭 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟱
📍 𝗚𝗘𝗡𝗘𝗥𝗔𝗧𝗢𝗥 𝗖𝗼𝘄𝗼𝗿𝗸𝗶𝗻𝗴, 𝗞𝘆𝗶𝘃 (𝗛𝗿𝘂𝘀𝗵𝗲𝘃𝘀𝗸𝗼𝗵𝗼 𝟯)
🎟 𝗣𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗳𝗿𝗲𝗲 — 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗱
🗣 𝗧𝗵𝗲 𝗲𝘃𝗲𝗻𝘁 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗵𝗲𝗹𝗱 𝗶𝗻 𝗨𝗸𝗿𝗮𝗶𝗻𝗶𝗮𝗻
🇺🇦 𝗙𝗼𝗿 𝗨𝗸𝗿𝗮𝗶𝗻𝗶𝗮𝗻 𝗣𝗩 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀

This is the first event in Ukraine fully dedicated to 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘁𝗵𝗲 𝘂𝘀𝗲 𝗼𝗳 𝗔𝗜 𝗶𝗻 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲, created to share knowledge, exchange experience, and strengthen our professional community.

What’s ahead:
🔹 Practical expert talks
🔹 A real automation case study by DrugCard
🔹 Two panel discussions: AI regulation (EMA/FDA) & complex literature assessment
🔹 Open Q&A forum
🔹 Launch of the Secret Drug Safety Club UA
🔹 Warm and purposeful networking

👉 Register here: https://drugcards-26507628.hubspotpagebuilder.eu/drug_safety_day

We look forward to welcoming everyone who is moving Ukrainian pharmacovigilance forward — together, even in difficult times 💙💛

18/11/2025

𝗪𝗼𝗿𝗹𝗱 𝗔𝗠𝗥 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗪𝗲𝗲𝗸 𝟮𝟬𝟮𝟱 𝗥𝗶𝗻𝗴𝘀 𝘁𝗵𝗲 𝗔𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗰 𝗔𝗹𝗮𝗿𝗺🧫
Every year, drug-resistant infections claim 35,000 lives in Europe alone - yet the real danger isn’t just resistance. It’s how quietly it grows.

‼️Behind every unexpected loss of efficacy, every prescription given “just in case,” and every overlooked pattern in medical literature, antimicrobial resistance is already shaping the future of medicine.
📢And this year’s theme - “Act Now: Protect Our Present, Secure Our Future” - says it all.

👉 Learn more in our latest blog article: https://drug-card.io/blog/listen-to-the-antibiotic-alarm-during-world-amr-awareness-week/

11/11/2025

🦸‍♂️𝗧𝗵𝗲 𝗗𝗮𝗶𝗹𝘆 𝗟𝗶𝗳𝗲 𝗼𝗳 𝗮 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁
Being a pharmacovigilance specialist is more than just filling out reports or coding adverse events. It’s about detective work, critical thinking, and a deep commitment to patient safety.

From assessing complex causality cases 🕵️‍♂️, to monitoring medical literature for rare adverse reactions 📚, to navigating endless regulatory deadlines ⏰ - PV specialists see the side of drug safety that most people never notice.

🔥Our latest blog post dives into 7 things only pharmacovigilance specialists truly understand. This article gives a behind-the-scenes look into the everyday life of PV specialists.
👉 Read the full article here: https://drug-card.io/blog/7-things-only-pharmacovigilance-specialist-truly-understand/

04/11/2025

#𝗠𝗲𝗱𝗦𝗮𝗳𝗲𝘁𝘆𝗪𝗲𝗲𝗸 𝟮𝟬𝟮𝟱 𝗶𝘀 𝗵𝗲𝗿𝗲! 🚨
“𝘞𝘦 𝘤𝘢𝘯 𝘢𝘭𝘭 𝘩𝘦𝘭𝘱 𝘮𝘢𝘬𝘦 𝘮𝘦𝘥𝘪𝘤𝘪𝘯𝘦𝘴 𝘴𝘢𝘧𝘦𝘳.” 💊

Did you know that less than 10% of side effects are reported? Every observation counts - from patients to healthcare professionals.
At DrugCard, we help pharmacovigilance specialists spot and analyse adverse reactions in the literature:

📚 Millions of articles monitored globally and locally
⚠️ 2,000+ adverse reaction cases identified
🔎 Quick and easy searches across languages and regions

This November, your report could save a life. Let’s make medicines safer - together 👉 https://drug-card.io/blog/medsafetyweek-2025-together-we-can-make-medicines-safer/

28/10/2025

💼𝗧𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝗮𝗯𝗼𝘂𝘁 𝗮 𝗰𝗮𝗿𝗲𝗲𝗿 𝗶𝗻 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲?
Here’s what you should know before you start.
Pharmacovigilance is often misunderstood as simple data entry or reporting adverse events. In reality, it’s a complex field that combines science, regulation, and human impact.

🚀The latest DrugCard Blog article explores what truly defines a successful PV specialist:
🔹 Critical thinking beyond data collection
🔹 Mastering regulatory frameworks and timelines
🔹 Balancing routine with responsibility
🔹 Developing communication and decision-making skills
🔹 Staying current with research, AI tools, and global safety updates

🔥If you’re entering the world of PV (or still recovering from your last PSUR), this blog is for you: https://drug-card.io/blog/what-you-should-know-before-starting-a-career-in-pharmacovigilance/

21/10/2025

𝗧𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗶𝘀 𝗵𝗲𝗿𝗲 — 𝗮𝗻𝗱 𝗶𝘁 𝗿𝗲𝗮𝗱𝘀 𝗳𝗼𝗿 𝘆𝗼𝘂!
Imagine never missing an important article and saving hours of manual work. Sounds futuristic? It’s already happening with AI in pharmacovigilance literature monitoring.

🚀Our latest DrugCard blog post shows how AI speeds up screening, extracts key data, and enables smarter collaboration — all in real time.

💡 Whether you’re just starting to automate your literature monitoring or exploring AI-powered tools, this post shows how the right technology can make your work faster, smarter, and more accurate.

Check out the full article here 👉 https://drug-card.io/blog/who-reads-all-the-pharmacovigilance-literature-for-you-with-ai/

14/10/2025

𝗪𝗵𝗲𝗻 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗠𝗲𝗲𝘁 𝗥𝗮𝗿𝗲 𝗦𝗮𝗳𝗲𝘁𝘆 𝗗𝗮𝘁𝗮
Rare diseases affect only a small 👥group of patients, which means limited incentives to develop treatments and, unfortunately, limited safety data once those treatments reach the market.

🎯Because orphan drugs target such small populations, adverse reactions are often underreported or go unnoticed. That’s why post-marketing pharmacovigilance is vital in uncovering real-world safety signals.

📚Even local medical literature monitoring can reveal valuable insights - cases that might never appear in global databases but are crucial for understanding the accurate safety profile of these rare therapies.
👉Discover more in our latest DrugCard blog post: https://drug-card.io/blog/orphan-drugs-and-what-makes-their-pharmacovigilance-unique/